MAT for OUD Tools & Resources    

This Opioid Prevention Campaign toolkit translates the science of prevention into simple strategies parents and caregivers can incorporate into busy daily lives -- to do what we can to protect our kids from developing an addiction later in life.

Provides information about the 2018 Arizona Opioid Epidemic Act for pharmacists and prescribers of opioids, including legal obligations.

Offers training programs on buprenorphine treatment of opioid dependence.

Assesses known opioid-related overdose risk behaviors.

Guides States, Tribes, and local communities on best practices for collaborative treatment approaches for women with SUDs. Highlights data on the effects of opioids on pregnant women and the risks and benefits associated with MAT.

This pocket guide is designed to help counselors and therapists working with drug court participants refer and link participants to opioid treatment services in outpatient offices, clinics, and Opioid Treatment Programs (OTPs).

This pocket guide is intended for non-clinical drug court team members (e.g., court coordinators, judges, defense attorneys, prosecutors, parole officers, case managers, peer mentors, recovery coaches). It will describe how the team member can support both the provider and those participants prescribed or considering medication-assisted treatment (MAT).

This guide is a resource for health care systems to improve mental health and well-being in the communities they serve, focusing specifically on saving lives from deaths of despair. The guide endeavors to provide a comprehensive framework in which multiple stakeholders (e.g., people from marginalized populations and communities and leaders in sectors such as health care, education, justice system, local government, employers) can identify themselves and their contributions. A specific emphasis is placed on the role of health care systems in impacting the care they deliver and leveraging all of their assets to improve the health of populations and communities.

Helps clinicians screen their patients for SUDs, conduct brief interventions for patients in the early stages of problem development, and appropriately refer more severely affected patients for indepth assessment and treatment.

Helps clinicians integrate naltrexone into their practice. Describes the rationale for using naltrexone in contrast to agonist approach, guidelines to select appropriate patients, clinical strategies to initiate treatment, safety concerns and management of side effects, and managing common clinical problems emerging during treatment with naltrexone.